Twist Bioscience Corporation (TWST) Tops Q4 EPS by 36c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
Twist Bioscience Reports Fiscal Fourth Quarter and Full Year Fiscal 2022 Financial Results
November 18, 2022 7:30 AM EST-- Record revenue of $203.6 million in Fiscal 2022; Increase of 54% over $132.3 million in Fiscal 2021
-- Orders increased to $226 million in Fiscal 2022; Increase of 42% over $160 million in Fiscal 2021 --
Expect revenue in the range of $261 million to $269 million for full year Fiscal 2023 --
Expect revenue of $350 million for full year Fiscal 2024 --
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--
... More